2023

1. Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

   Transplantation and Cellular Therapy, Vol. 29, Núm. 7, pp. 430-437